Skip to content
← Back to this collection

PUBLICATIONS · 31331699

Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2019 Sep
First author
Toulmonde M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 Sep;20(9):1190-1192. doi: 10.1016/S1470-2045(19)30323-7.
    note
    Source null
    related pmid
    31331700
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2019 Oct;20(10):e555. doi: 10.1016/S1470-2045(19)30543-1.
    note
    Source null
    related pmid
    31578997
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2019 Oct;20(10):e556. doi: 10.1016/S1470-2045(19)30575-3.
    note
    Source null
    related pmid
    31578998
    relationship
    Comment in

Authors and identifiers

  1. name
    Toulmonde M
    type
    Author
  2. name
    Pulido M
    type
    Author
  3. name
    Ray-Coquard I
    type
    Author
  4. name
    Andre T
    type
    Author
  5. name
    Isambert N
    type
    Author
  6. name
    Chevreau C
    type
    Author
  7. name
    Penel N
    type
    Author
  8. name
    Bompas E
    type
    Author
  9. name
    Saada E
    type
    Author
  10. name
    Bertucci F
    type
    Author
  11. name
    Lebbe C
    type
    Author
  12. name
    Le Cesne A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Toulmonde M
    type
    Author
  2. name
    Pulido M
    type
    Author
  3. name
    Ray-Coquard I
    type
    Author
  4. name
    Andre T
    type
    Author
  5. name
    Isambert N
    type
    Author
  6. name
    Chevreau C
    type
    Author
  7. name
    Penel N
    type
    Author
  8. name
    Bompas E
    type
    Author
  9. name
    Saada E
    type
    Author
  10. name
    Bertucci F
    type
    Author
  11. name
    Lebbe C
    type
    Author
  12. name
    Le Cesne A
    type
    Author
bibliography ids
  1. nci-bib-7f46a9dd3b5aee64147e075d
book metadata
content sha256
af61643703c96f14717bfc729daa3eeb3c3b630c8f100bf5a8ab16db69e46f3d
document type
citation
dois
  1. 10.1016/S1470-2045(19)30276-1
electronic publication date
display
2019 Jul 19
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31331699
immutable id
pubmed:31331699@af61643703c96f14717bfc729daa3eeb3c3b630c8f100bf5a8ab16db69e46f3d
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
9
name
The Lancet. Oncology
nlm unique id
100957246
pages
1263-1272
volume
20
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 Sep;20(9):1190-1192. doi: 10.1016/S1470-2045(19)30323-7.
    note
    Source null
    related pmid
    31331700
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2019 Oct;20(10):e555. doi: 10.1016/S1470-2045(19)30543-1.
    note
    Source null
    related pmid
    31578997
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2019 Oct;20(10):e556. doi: 10.1016/S1470-2045(19)30575-3.
    note
    Source null
    related pmid
    31578998
    relationship
    Comment in
outcomes validated
false
pmid
31331699
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
f86eeeeb30e304dce02c527531ea40598c7562b14ed7509dc582efb7ff4d716e
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Sep
precision
month
year
2019
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31331699/
title
Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.

Preserved source evidence · Not medical advice